Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy

Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy

Our goal in this work was to illustrate the Epstein-Barr virus (EBV)-modulated global biochemical profile and provide a novel metabolism-related target to improve the therapeutic regimen of nasopharyngeal carcinoma (NPC). We used a metabolomics approach to investigate EBV-modulated metabolic changes...

Full description

Bibliographic Details
Main Authors: Xiao, L, Hu, Z-y, Dong, X, Tan, Z, Li, W, Tang, M, Chen, L, Yang, L, Tao, Y, Jiang, Y, Li, J, Yi, B, Li, B, Fan, S, You, S, Deng, X, Hu, F, Feng, L, Bode, A M, Dong, Z, Sun, L-q, Cao, Y
Format: Online
Language:English
Published: Nature Publishing Group 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162460/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162460/

Similar Items